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Abstract
Background: In older adults, depression has been associated with increased fall risk, but the
reasons for this link are not fully clear. Given parallels between major depression and Parkinson's
disease, we hypothesized that major depression and related affective disorders would be associated
with impairment in the ability to regulate the stride-to-stride fluctuations in gait cycle timing.
Methods:  We measured stride-to-stride fluctuations of patients with two forms of mood
disorders, unipolar major depressive disorder (MDD) and bipolar disorder, and compared their
gait to that of a healthy control group. The primary outcomes were two measures of gait
unsteadiness that have been associated with fall risk: stride time variability and swing time
variability.
Results: Compared to the control group, the two patient groups tended to walk more slowly and
with decreased swing time and increased stride time. However, none of these differences was
statistically significant. Compared to the control group, swing time variability was significantly larger
in the subjects with bipolar disorder (p < 0.0001) and in the subjects with MDD (p < 0.0004).
Conclusions: Patients with MDD and patients with bipolar disorder display gait unsteadiness. This
perturbation in gait may provide a mechanistic link connecting depression and falls. The present
findings also suggest the possibility that measurement of variability of gait may provide a readily
quantifiable objective approach to monitoring depression and related affective disorders.
Background
In older adults, depression has been associated with
increased fall risk [1,2]. Epidemiological studies indicate
that older adults who are more depressed have an
increased risk of falls and fractures compared to their
aged-matched peers and that this association persists even
after adjusting for potential confounding effects such as
medication usage [3-5]. The reasons for this link between
depression and falls are not fully clear [3]. People with
major depression have been shown to walk more slowly,
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with decreased push-off and more time spent with both
feet on the ground [6-8]. These gait changes, however, do
not necessarily explain the increased risk of falls associ-
ated with depression [9,10]. One possibility is that these
two syndromes simply share common risk factors [11].
Alternatively, there may be some cause and effect influ-
ences mediating the association between depression and
falls. For example, depression may not only lead to a
slowed gait, but it could induce gait unsteadiness and a
reduction in the ability to maintain a stable walking pat-
tern. Cross-sectional studies suggest that individuals who
report more signs of depression tend to be less steady on
their feet [12,13]. To date, however, no studies have
directly examined the dynamics of gait unsteadiness of
patients with major depression or related affective
disorders.
Parallels between Parkinson's disease and depression also
support the possibility of gait unsteadiness in the latter.
Psychomotor studies have revealed deficits in the motor
performance of persons with major depression similar to
some of the motor disturbances observed in Parkinson's
disease [14,15]. In both groups of patients, slowed motor
performance can be seen in speech, simple reaction time
tests, and gait [14-17]. Furthermore, in both groups, imag-
ing studies reveal shrunken basal ganglia, the motor area
primarily affected in Parkinson's disease, and changes in
other dopamine dependent neural circuits [15]. In Parkin-
son's disease, basal ganglia dysfunction not only causes
slowed movements, but also contributes to gait unsteadi-
ness and increased stride-to-stride variability [18-20], a
marker of fall risk [10,12,20,21].
Given the associations between fall risk and depression
and the parallels between major depression and Parkin-
son's disease, we hypothesized that major depression and
related affective disorders would be associated with gait
unsteadiness and impairment in the ability to regulate the
dynamics of gait stability. To this end, we measured the
stride-to-stride fluctuations in the gait cycle timing of
patients with two forms of mood disorders, unipolar
major depressive disorder (MDD) and bipolar disorder,
and compared their gait to that of a healthy control group.
The primary outcomes were two measures of gait unstead-
iness: stride time variability and swing time variability
[12,19,20]. We anticipated that these two variability
measures would be increased in the two patient groups
compared to the control group. In secondary analyses, we
examined the potential confounding influences of age,
medications and other subject characteristics on these two
measures of variability.
Methods
Subjects
Patients with a clinically defined major affective disorder
were recruited from the clinics of McLean Hospital, a psy-
chiatric teaching center in Belmont, MA. Specifically,
patients were invited to participate if they were being
treated for either bipolar disorder or unipolar MDD, as
defined by DSM-IV criteria [22]. Patients were excluded if
they had clinically significant co-morbidities likely to
affect gait including orthopedic disease, dementia, neuro-
logical disease, podiatry complaints or any known gait
disturbances. To quantify disease severity, we used the
Clinical Global Impression Scale (0: healthy; 7 most
severe) [23]. Healthy subjects without depression, other
affective disorders, or any of the above-mentioned co-
morbidities likely to affect gait were recruited from among
hospital employees and the community to serve as a
healthy control group. The Human Studies committee of
McLean Hospital approved the study. All subjects pro-
vided informed written consent prior to participating in
the study.
Assessment of gait unsteadiness
Subjects were instructed to walk at their normal pace on
level ground for 35 meters, to turn and to walk the same
route back, and to continue walking for a total of six min-
utes. Study subjects were not aware of the specific ques-
tions addressed in this investigation.
Previously described methods were used to evaluate gait
dynamics and analyze the stride-to-stride fluctuations of
gait timing [12,19,20]. Briefly, to measure the gait rhythm
and the timing of the gait cycle (i.e., the stride time and
the % swing time), force sensitive insoles were placed in
the subject's shoes. These inserts produce a measure of the
force applied to the ground during ambulation. A small,
lightweight (5.5 × 2 × 9 cm; 0.1 kg.) recorder was worn on
the ankle and held in place using an ankle wallet. An on
board A/D converter (12 bit) sampled the output of the
footswitches at 300 Hz and stored the data. Subsequently,
the digitized data were transferred to a computer worksta-
tion for analysis using software that extracts the initial and
end contact time of each stride (i.e., heel-strike and toe-
off). With this information, the stride time or duration of
the gait cycle (time from initial contact of one foot to sub-
sequent contact of the same foot) and the % swing time
were determined for each stride during the walk. The
stride time is a measure of the gait cycle duration and the
inverse of the cadence. The time spent with one foot in the
air, relative to the gait cycle duration, defines the % swing
time. Typically, the % swing time becomes smaller in dis-
eases that affect gait (e.g., Parkinson's disease).
To focus on the assessment of the intrinsic dynamics of
continuous, usual walking and gait unsteadiness and toBMC Psychiatry 2004, 4:39 http://www.biomedcentral.com/1471-244X/4/39
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insure that the analysis was not influenced by outlier data
points, previously described analysis methods were used
[12,19,20]. Briefly, the first thirty seconds of each subject's
walking time series were excluded to minimize any start-
up effects and the last ten seconds were removed as well
[12,19,20]. A median filter was then applied to each sub-
ject's time series to remove data points that were three
standard deviations greater than or less than the median
value of each time series [12,13,19]. The mean stride time
and mean % swing time were computed. Two measures of
stride-to-stride variability [12,19,20] were also assessed.
1) Stride time variability, the magnitude of the stride-to-
stride fluctuations in the gait cycle duration, was calcu-
lated by determining the coefficient of variation (CV) of
each subject's stride time. 2) Swing time variability was
determined by calculating the % swing time CV. Values
reported are for the left foot. Similar results were obtained
if we analyzed each subject's right foot or the "best" foot
(i.e., the one with the lowest variability). These two meas-
ures of stride-to-stride variability reflect gait unsteadiness
and have been shown to be related to fall risk, i.e., larger
variability has been associated with increased risk of falls
[12,20]. Mean gait speed was evaluated by determining
the time required to walk 6 laps (i.e., 210 meters).
Statistical analysis
Results are reported as means ± standard deviation. For
continuous data, the Wilcoxon Rank Sum test (the non-
parametric equivalent of the two-sample Student's t-test)
was used to compare each patient group to the control
group (We note that for all of the primary outcomes the
conclusions were unchanged if parametric analyses were
applied instead). Subgroup analyses were performed to
evaluate the effects of subject characteristics such as age
and use of certain drugs. A p-value less than or equal to
0.01 was considered statistically significant (Bonferroni-
like adjustment for the five measures of gait). Statistical
analysis was performed using SPSS for Windows (version
10.1).
Results
Subject characteristics
Fifty subjects (17 women) were studied. Subjects were
36.3 ± 14.7 years old. Twenty-three of the subjects had
bipolar disorder (mean age: 43.4 ± 14.2 yrs), nine subjects
had MDD (mean age: 40.9 ± 16.9 yrs), and eighteen of the
subjects were healthy controls (mean age: 24.9 ± 3.5 yrs).
Scores on the Clinical Global Impression (CGI) scale were
0.2 ± 0.4, 3.8 ± 0.9, and 3.2 ± 0.7 for the control, bipolar
and MDD groups, respectively. As expected, the mean CGI
scores were significantly higher in both patient groups
compared to the control group (p < 0.001 for both
groups).
Gait changes in bipolar disorder and MDD
Table 1 summarizes the gait measurements of the three
groups. Compared to the control group, the two patient
groups tended to walk more slowly, with decreased swing
time % and increased stride time. However, none of these
differences was statistically significant (e.g., for gait speed,
p = 0.32 and 0.10 in patients with bipolar disorder and
MDD compared to controls, respectively). As hypothe-
sized, stride time variability tended to be larger in both
patient groups compared to the control group, but the dif-
ferences were not significant (p > 0.29). Compared to the
control group, swing time variability was significantly
larger in the subjects with bipolar disorder (p < 0.0001)
and in the subjects with MDD (p < 0.0004). These meas-
ures of gait were not significantly different between the
two patient groups. Examples of time series showing the
increased stride-to-stride fluctuations in swing time % in
a subject with bipolar disorder and a subject with MDD
are shown in Figure 1.
All but one of the subjects with MDD was being treated for
acute illness, as were nineteen of the subjects with bipolar
disorder. Among the subjects with bipolar disorder, the
subjects whose disease was stable tended to walk more
normally (closer to control values) compared to those
subjects with bipolar disorder being treated acutely. Swing
time variability tended to be larger (p = 0.044) in the sub-
jects with bipolar disorder who were being treated acutely
(3.2 ± 1.5 %) compared to those who were more clinically
stable (2.2 ± 0.3 %).
Among the subjects with MDD, swing time variability
tended to be higher in subjects on antidepressants (n = 5)
compared to subjects not taking antidepressants (p =
0.027). Other measures of gait and the CGI were similar
in the MDD subjects who were on or off antidepressants
(p > 0.41). One patient with MDD was taking a neurolep-
tic and none was taking mood stabilizers. Among bipolar
patients, there were no significant differences in any of the
gait measures in patients who were taking antidepressants
(n = 15), neuroleptics (n = 14) or mood stabilizers (n =
12) compared to those who were not. Compared to
controls, swing time CV was significantly increased
among bipolar patients who were not taking antidepres-
sants (p < 0.001), not taking neuroleptics (p < 0.002) or
not taking mood stabilizers (p < 0.001). Stride time CV
tended (p = 0.068) to be increased among bipolar patients
who were taking antidepressants, neuroleptics, or mood
stabilizers (n = 17), compared to those who were not (n =
6). Compared to the controls, swing time CV was signifi-
cantly increased among the six bipolar patients who were
not taking antidepressants, neuroleptics or mood stabiliz-
ers (p < 0.007).BMC Psychiatry 2004, 4:39 http://www.biomedcentral.com/1471-244X/4/39
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Subjects in the two patient groups were generally older
than the subjects in the control groups. To evaluate if the
group effects were only a result of these age differences, we
analyzed the subset of all the subjects who were less than
forty years of age. In this subgroup (n = 32), mean ages of
all three groups were similar (p > 0.32) and CGI scores
remained significantly higher in the two patient groups
compared to the control group (p < 0.0001). The results
of this subset analysis are consistent with those shown in
Table 1. For example, gait speed was similar among the
younger subjects with bipolar disorder compared to the
younger control subjects (p = 0.185) and among the
younger subjects with MDD compared to the younger
control subjects (p = 0.075). Among the subjects who
were less than forty years old, swing time variability was
significantly higher in the subjects with bipolar disorder
compared to the control subjects (p = 0.010) and in the
subjects with MDD compared to the control subjects (p =
0.002).
Discussion
Previous studies reported that patients with clinical
depression walk more slowly and with less time spent in
the swing phase of the gait cycle [6,7]. The present find-
ings lend support to those reports. Although the differ-
ences were not statistically significant in this study,
subjects with MDD and subjects with bipolar disorder
generally tended to walk more slowly and with a short-
ened swing phase compared to the control group. Here we
report, for the first time, changes in the stride-to-stride
variability of these two patient groups. In both MDD and
bipolar disorder, significant increases in swing time varia-
bility were observed. This finding raises the intriguing
possibility that dynamic instabilities in the walking pat-
tern may be a heretofore unrecognized feature of gait in
severe clinical depression and related affective disorders,
including subjects with MDD and bipolar disorder. To our
knowledge, this is the first quantitative investigation of
gait in bipolar disorder patients.
Although not necessarily apparent to the clinical observer,
the present quantitative study suggests that severe clinical
depression and related major affective disorders may be
Table 1: Gait dynamics in the three subject groups
Gait Measure Healthy Controls 
(n = 18)
Bipolar Disorder 
(n = 23)
Unipolar Major Depressive 
Disorder 
(n = 9)
Mean Values Stride time (msec) 1120 ± 69 1161 ± 106 1200 ± 94
Swing Time (%) 37.0 ± 1.6 35.4 ± 2.1 35.8 ± 1.3
Gait speed (m/sec) 1.21 ± 0.16 1.14 ± 0.20 1.11 ± 0.14
Variability Measures of Unsteadiness Stride Time CV (%) 2.4 ± 0.6 2.9 ± 1.3 2.6 ± 0.9
Swing Time CV (%) 1.9 ± 0.3 3.0 ± 1.4* 3.6 ± 1.9*
CV: coefficient of variation
* p < 0.0005 compared to the control group
Representative swing time series from two patients with  affective disorders and a control subject Figure 1
Representative swing time series from two patients 
with affective disorders and a control subject. Data 
shown are from a healthy control subject (25 yr old male; 
swing time CV = 1.6 %), a subject with major depressive dis-
order (38 yr old male; swing time CV = 3.2 %), and a subject 
with bipolar disorder (20 yr old male; swing time CV = 3.7 
%). Note the relatively large stride-to-stride fluctuations 
(increased variability) in the swing time of the two patients 
compared with the control subject.
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associated with an unsteady gait, with certain features
reminiscent of impairments in Parkinson's disease. There
are, however, subtle but important differences. In
advanced Parkinson's disease [18,19], gait speed and
swing time are typically reduced to a much greater extent
than that seen in the present study (e.g., one study
reported a mean gait speed of 1.0 m/sec and a mean %
swing time of 33.5 % in subjects with Parkinson's disease
[19]; compare with Table 1). In Parkinson's disease,
increased stride-to-stride variability is seen in the swing
time (as in the present study), but the magnitude of the
increase in swing time variability is larger than that seen
in MDD and bipolar disorder [19]. For example, a previ-
ous study found that the mean stride time variability and
swing time variability were 4.4 % and 5.7 %, respectively,
among patients with Parkinson's disease [19], values that
are much higher than those observed in the present study
(compare with Table 1). In addition, whereas in Parkin-
son's disease increased variability is observed in the stride
time as well as in swing time, in MDD and bipolar disor-
der the gait impairment appears in swing time regulation
and the alterations are smaller than those observed in Par-
kinson's disease.
In some previous studies that have examined both stride
time variability and swing time variability, an increase in
one measure was accompanied by an increase in the other
measure [12,19]. This observation is not surprising since
swing time is a key component of gait cycle timing and a
sub-phase of the stride time. An interesting question is
why increased swing time variability was observed among
the patients with MDD and bipolar disease in the present
study, while stride time variability was not significantly
increased? A number of explanations may be possible.
Our findings suggest that in some circumstances swing
time variability may be a more sensitive marker of subtle
underlying changes in neural control and in the locomo-
tor system's ability to repeatedly and precisely generate
and execute neural commands. While stride time variabil-
ity evaluates consistency of the loading response, as
reflected in the variability in the time between consecutive
heel-strikes, swing time variability reflects the stride-to-
stride consistency of both the loading and unloading of
body weight. Thus, when the regulation of gait is largely
intact and stride-to-stride variability is relatively small, as
in the present study, changes in swing time variability may
be present, while stride time variability remains largely
unchanged.
Another related explanation for the discrepancy been
stride time variability and swing time variability has been
suggested by Gabell and Nayack [24]. They proposed that
stride time variability reflects gait patterning mechanisms
and the rhythmicity of locomotor pacing while variability
of stance and swing time more closely mirror dynamic
equilibrium and postural control mechanisms. A com-
plete explanation for the difference between swing time
variability and stride time variability requires further
investigation. We note, however, that such discrepant
behavior among different measures of gait variability has
also been observed in other studies [25-28]. For example
in a study of patients with very mild Parkinson's disease
[27], swing time variability was significantly increased
while stride time variability was only slightly larger than
control values.
In older adults, depression is associated with an increase
in the risk of falls and hip fractures [1,3]. The mechanisms
responsible for this increase are not clear. The present
findings suggest that depression and bipolar disorder may
be associated with an increase in stride-to-stride variabil-
ity which may, in turn, predispose to falls [10,12,20,21].
Young and middle-aged adults who are depressed gener-
ally do not have an increased fall risk, probably because
depression by itself does not increase stride variability
enough to cause falls and because other physiologic sys-
tems that help maintain gait and balance stability are gen-
erally intact. In older adults, falls are often multifactorial
[1]. If age-associated changes occur in multiple systems
(e.g., vision, balance), depression may further contribute
to fall risk by increasing stride variability and exacerbating
instability. One possibility is that the changes in basal
ganglia function in depression [15] increase stride varia-
bility, as occurs in Parkinson's disease; however, the
mechanisms whereby depression and other affective dis-
orders influence gait and impair the regulation of stride
variability remain to be determined.
A previous study of gait in depression did not find any sig-
nificant differences in the gait of subjects who were taking
medications compared to those who were not [6]. Specif-
ically, gait speed, stride time and swing time were appar-
ently not related to medication usage. For these specific
features of gait, our results support the previous findings.
Gait speed and stride time were not related to medication
usage in the subjects with bipolar disorder or MDD in the
present study. Conversely, while swing time variability
was increased relative to control values even in the sub-
group of bipolar patients who were not taking any medi-
cations, among the patients with bipolar disease and the
patients with MDD taking certain medications, variability
of gait measures tended to be further increased. Although
Lemke et al. did not find a medication effect on gait in
patients with depression [6], the suggested relationship
between gait and medication usage in the present study in
the subjects with MDD is consistent with a recent study
which reported that certain antidepressants may impair
psychomotor abilities and integrative central nervous sys-
tem function [29]. However, it is not apparent why such
an effect was not observed among patients with bipolarBMC Psychiatry 2004, 4:39 http://www.biomedcentral.com/1471-244X/4/39
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disease and why antidepressants might affect the swing
time variability of patients with MDD, but not of patients
with bipolar disease.
This preliminary study has a number of limitations. As
noted, subjects in the control group were generally
younger than the two patient groups (mean differences of
4 and 7 years). However, a number of considerations sug-
gest that the observed increase in swing time variability in
the patient groups was not simply a function of aging. 1)
Subgroup analysis demonstrates that the differences
between the groups persist even when only the relatively
young subjects (< 40 years of age) are studied. 2) Like the
variability of gait speed and stride length, previous work
has shown that the variability of stride time and swing
time is similar in healthy young and healthy older adults,
and that increases in older adults are a sign of pathology
[24-26,30-32]. For example, one study of the effects of
physiologic aging on gait found stride time variability was
essentially identical in a group of healthy young adults
(mean age 24.6 years) and healthy older adults (mean age
75.7 yrs) [31], with values similar to those observed in the
present study.
The present study has other limitations and raises addi-
tional questions that should be addressed in future stud-
ies. Among subjects with MDD, we could not evaluate if
there were differences between subjects treated for acute
illness and those with more chronic symptoms. Further,
among patient with bipolar disorder, we did not control
for the patients' acute mood status. The present study may
have also been underpowered to detect small differences
between the patients with bipolar disorder and MDD. A
prospective study of a larger number of patients, perhaps
in different age groups before and after they undergo dif-
ferent types of therapy, including pharmacologic interven-
tions, should be helpful in leading to a more complete
understanding of the relationships among stride variabil-
ity, fall risk, and medication usage. Such studies may also
be helpful in determining the mechanisms whereby
depression and related mood disorders influence stride
variability, in assessing how this relationship changes over
time and with respect to disease state (i.e., acute or stable
symptoms), and in evaluating if stride variability meas-
ures may prove clinically useful as an objective measure of
major affective disorders. Stride variability is less affected
by a conscious effort to alter gait and more closely reflects
intrinsic underlying impairment [10]. Additional biome-
chanical studies may also be helpful in elaborating the
mechanisms underlying gait changes in affective disorders
and possible causal links between swing time variability,
gait instability, and the risk of falls.
Conclusions
Despite the limitations of this study, the present findings
in a relatively small sample size indicate that patients with
MDD and patients with bipolar disorder display gait
unsteadiness evidenced by increased swing time variabil-
ity, even while other measures of gait are not markedly
changed. This apparent disparity between measures of
stride variability, on the one hand, and gait speed and
other features of gait, on the other, raises the possibility
that stride-to-stride variability  in major mood disorders
may be more sensitive to certain subtle neuropsychiatric
influences than measures based only on the mean value of
a given parameter. Our findings also demonstrate that
measurement of variability of gait may provide a readily
quantifiable approach to monitoring depression and
other affective disorders. Moreover, these results suggest
that this perturbation in gait dynamics may provide a
mechanistic link connecting depression and falls in older
adults.
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